Research · Sep 3, 2026
[WLY] John Wiley & Sons Thesis 2026: An Academic-Publishing + Research + AI Compounder
John Wiley & Sons, Inc. (NYSE: WLY), headquartered in Hoboken, New Jersey, is an Academic-Publishing-and-Research-Solutions + emerging-multi-cycle-AI-and-Open-Access-Research leader providing distinctive multi-cycle Academic-Publishing + emerging-Research + emerging-AI-and-Open-Access-Research + emerging-Wiley-AI-Solutions services to substantial multi-cycle US-and-emerging-multi-cycle-international Academic-Institution (Harvard + MIT + Stanford + Berkeley + Oxford + Cambridge + Sorbonne) + Research-Library + emerging-multi-cycle-Pharmaceutical-and-Biotech-Research customer base. Distinctive multi-cycle Wiley-and-Hoboken-NJ-and-Academic-Publishing heritage: founded 1807 by Charles Wiley + multi-cycle-Wiley-family-controlled; 1962 NYSE Wiley-IPO; 2007 substantial Blackwell-Publishing-acquisition (~$1.13B); 2021 substantial Hindawi-Open-Access-acquisition; 2024 substantial University-Services-divestiture-to-Cengage-Group (~$150M); 2024 Matthew Kissner CEO. Multi-decade strategic-evolution: 1807 Wiley founding; 1962 NYSE-IPO; 2007 Blackwell-Publishing; 2010-2020 Open-Access-Research-emergence + multi-cycle-disciplined-bolt-on-M&A; 2021 Hindawi-Open-Access; 2024 University-Services-divestiture; 2024 Matthew Kissner CEO; 2020-2025 substantial multi-cycle post-COVID + emerging-Academic-Publishing-and-Research + emerging-AI-and-Open-Access-Research + emerging-Wiley-AI-Solutions + emerging-LLM-Training-Data. Under President & CEO Matthew Kissner (since 2024 interim-to-permanent, ~1+ year longtime-Wiley-Board-and-Pitney-Bowes-and-MasterCard entrepreneur), FY2026 (Apr-FYE) closes with selected various aggregate revenue ~$1.65-1.85B, adj. EBITDA ~$340-405M, adj. EPS ~$3.10-3.85, net debt ~$0.65-0.85B, and ~54-56M shares outstanding. The first deep-dive — Academic-Publishing-and-Research-and-Learning-and-AI franchise — covers entire business + Wiley positioning. Geographic + Employee composition: ~4,500+ employees + ~globally-positioned-Academic-Publishing-and-Research-and-Learning-and-AI-facilities across US (Hoboken-NJ-HQ + Multi-Office) + emerging multi-jurisdiction-international (UK-Oxford-Cambridge + Germany-and-France + India + China-and-Asia). Revenue mix: Academic-Publishing-and-Research-and-Learning-and-AI ~95-99% (Research-largest ~70-75% + Learning ~20-25% + Hindawi-Open-Access + Wiley-AI-Solutions); Emerging-Other ~1-5%. Customer base: Academic-Institution (Harvard + MIT + Stanford + Berkeley + Oxford + Cambridge + Sorbonne + emerging-Asia + emerging-Africa) + Research-Library + emerging-Pharmaceutical-and-Biotech-Research + emerging-Corporate-R-and-D + emerging-AI-and-LLM-Training-Data. Distinctive multi-cycle 2007-Blackwell-Publishing + 2021-Hindawi-Open-Access + 2024-University-Services-Divestiture. Competes with Elsevier (RELX-REL-LN-subsidiary largest-Academic-Publishing most-direct-larger-Elsevier-comp), RELX Group (REL-LN), Springer Nature (private + BC-Partners-Holtzbrinck + emerging-IPO), Wolters Kluwer (WKL-AS), Pearson (PSON-LN), McGraw Hill (Platinum-Equity-take-private 2021), Cengage Group (private + Apollo + 2024-Wiley-University-Services-acquired ~$150M), Oxford University Press (Oxford-University-affiliated), Cambridge University Press (Cambridge-University-affiliated), Sage Publications (private), Taylor & Francis (Informa-INF-LN-subsidiary), Informa (INF-LN), American Chemical Society (ACS-Publications-nonprofit), Royal Society of Chemistry (RSC-UK-nonprofit), IEEE (IEEE-Publications-nonprofit), PLOS (private + nonprofit), eLife (private), F1000 (Taylor-Francis-Informa-subsidiary), MDPI (private + largest-OA), Frontiers (private + Open-Access), Hindawi (Wiley-acquired 2021); Higher-Education-and-K-12 Pearson (PSON-LN), McGraw Hill (Platinum-Equity-private), Cengage (private), Oxford University Press, Cambridge University Press, Houghton Mifflin Harcourt (Veritas-Capital-private 2022); AI-and-LLM-Training-Data Microsoft (MSFT + Microsoft-OpenAI + Azure-AI), Alphabet (GOOG + Google-Gemini), Amazon (AMZN + AWS-Bedrock + Anthropic-investment), Meta Platforms (META + Llama), OpenAI (private), Anthropic (private + Claude), xAI (private + Grok), Cohere (private), Mistral AI (private), Hugging Face (private), Inflection AI (Microsoft-acquired 2024), Stability AI (private), Databricks (private), Snowflake (SNOW), Palantir (PLTR + AIP), C3.ai (AI), SoundHound AI (SOUN), BigBear.ai (BBAI), Tencent (700-HK), Alibaba (BABA + Qwen-AI), ByteDance (private + Doubao); Pharmaceutical-Biotech-Research Pfizer (PFE), Johnson & Johnson (JNJ), Merck (MRK), Eli Lilly (LLY), Bristol Myers Squibb (BMY), AbbVie (ABBV), Novartis (NVS), Roche (ROG-SW), GSK (GSK), AstraZeneca (AZN), Sanofi (SAN-PA), Bayer (BAYN-DE), Boehringer Ingelheim (private), Novo Nordisk (NVO), Vertex Pharmaceuticals (VRTX), Regeneron (REGN), Gilead (GILD), Biogen (BIIB), Amgen (AMGN), Moderna (MRNA), BioNTech (BNTX); private-equity-Publishing BC Partners (private + Springer-Nature), Holtzbrinck Publishing (private + Springer-Nature), Platinum Equity (private + McGraw-Hill 2021), Apollo (APO + Cengage-historical), Veritas Capital (private + HMH 2022), Thoma Bravo (private). The second deep-dive — Matthew-Kissner + 2007-Blackwell + 2021-Hindawi + 2024-University-Services-Divestiture + multi-decade compounder thesis — covers Matthew-Kissner-CEO (~1+ year longtime-Wiley-Board-and-Pitney-Bowes-and-MasterCard entrepreneur) expertise + Founder Charles Wiley (1807 historical) + multi-cycle-Wiley-family-controlled-Capital-Management leadership-continuity, 1962-NYSE-IPO + 2007-Blackwell + 2021-Hindawi + 2024-University-Services-divestiture + multi-cycle-Wiley-family-controlled transformational-platform + multi-cycle-disciplined-bolt-on-M&A, emerging-Academic-Publishing-and-Research + emerging-AI-and-Open-Access-Research + emerging-Wiley-AI-Solutions + emerging-LLM-Training-Data structural-tailwinds. Multi-cycle reliable-and-emerging-growing-dividend (~$1.40/yr ~3.5-5.0% yield ~25+ year continuous) + multi-cycle-modest-share-buyback ($60-150M/yr). Multi-decade compounder thesis combines Wiley-and-Hoboken-NJ ~218+ year heritage (founded 1807 + 1962 NYSE-IPO + multi-cycle-Wiley-family-controlled), ~4,500+ employees + ~globally-positioned-Academic-Publishing-facilities, 2007-Blackwell + 2021-Hindawi + 2024-University-Services-divestiture + multi-cycle-disciplined-bolt-on-M&A, Matthew Kissner + Pitney-Bowes + MasterCard + Wiley-family expertise, multi-cycle reliable-and-emerging-growing-dividend + multi-cycle-modest-share-buyback + IG-equivalent-emerging balance-sheet, emerging-Academic-Publishing-and-Research + emerging-AI-and-Open-Access-Research + emerging-Wiley-AI-Solutions + emerging-LLM-Training-Data structural-tailwinds. Capital position is IG-equivalent-emerging (Baa3/BBB-), dividend-reliable-and-emerging-growing + multi-cycle-modest-share-buyback, conservative-and-Academic-Publishing-leveraged: net debt ~$0.65-0.85B (~1.8-2.5x leverage), Baa3/BBB- equivalent, $0.10-0.20B liquidity, $1.40/yr dividend (~3.5-5.0% yield, ~35-45% payout, ~25+ year continuous) + ~$60-150M/yr buyback + multi-cycle-disciplined-bolt-on-M&A + emerging-Academic-Publishing-and-AI capex, ~54-56M shares. At ~$28-50 per share, equity value ~$1.5-2.8B, EV ~$2.2-3.6B, ~9-15x EPS and ~6.0-9.0x EV/EBITDA. Base case: Academic-Publishing-and-Research constructive + emerging-AI-and-Open-Access-Research + emerging-Wiley-AI-Solutions + revenue $1.70-1.90B + adj. EBITDA $360-425M + adj. EPS $3.35-4.20 + dividend hiked + ~5-15% return. Bull case: Academic-Publishing accelerates + emerging-AI-and-Open-Access-Research inflects-substantially + emerging-Wiley-AI-Solutions inflects-substantially + emerging-LLM-Training-Data inflects + revenue $1.80-2.00B + adj. EPS $3.70-4.65 + dividend hiked + selective-M&A + emerging-strategic-acquisition-target (Elsevier-RELX + Springer-Nature + Wolters-Kluwer + Pearson + McGraw-Hill + Cengage + Oxford-University-Press + Cambridge-University-Press + Sage + Taylor-Francis-Informa + ACS + RSC + IEEE + private-equity-Publishing-BC-Partners-Holtzbrinck-Platinum-Apollo-Veritas-Thoma-Bravo interest) + re-rate 11-18x + 25-50%+ return + takeout-premium-upside. Bear case: Academic-Publishing stresses + emerging-AI-and-Open-Access-Research disappoints + adj. EPS $2.00-2.50 + de-rate 6-9x + flat-to-substantially-negative.